PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16829497-11	2006	The main difference was the absence of IFNgamma and TNFalpha in TMJ CPA patients and a stronger TGFbeta and IL-1alpha expression.	cpa	68-71	interferon gamma	Homo sapiens	39-47	
34850023-6	2022	In comparison to controls, patients with CPA had significantly reduced production of IFNgamma in response to stimulation with beta-glucan+IL-12 (312 vs 988 pg/ml), LPS+IL-12 (252 vs 1033 pg/ml), ZYM+IL-12 (996 vs 2347 pg/ml), and IL-18+IL-12 (7193 vs 12330 pg/ml).	cpa	41-44	interferon gamma	Homo sapiens	85-93	
34850023-8	2022	CONCLUSION: Patients with CPA show impaired IFNgamma production in peripheral blood in response to stimuli.	cpa	26-29	interferon gamma	Homo sapiens	44-52	
34850023-10	2022	Immunotherapy with IFNgamma could be beneficial for patients showing impaired IFNgamma production in CPA.	cpa	101-104	interferon gamma	Homo sapiens	19-27	
34850023-10	2022	Immunotherapy with IFNgamma could be beneficial for patients showing impaired IFNgamma production in CPA.	cpa	101-104	interferon gamma	Homo sapiens	78-86	
30333797-9	2018	CPA patients did not differ significantly in the BALF cytokine profile compared to patients with respiratory disorders without CPA, but showed significant higher values for IFN-gamma, IL-1b, IL-6, IL-8, and TNF-alpha compared to healthy individuals.	cpa	0-3	interferon gamma	Homo sapiens	173-182